Tuesday, November 5, 2024

ODAIA Partners with Veeva to Accelerate Adoption of AI in Life Sciences

Related stories

Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI

Absci Corporation a data-first generative AI drug creation company, and...

GreyNoise Intelligence Discovers Zero-Day Vulnerabilities in Live Streaming Cameras with the Help of AI

GreyNoise Intelligence, the cybersecurity company providing real-time, verifiable threat...

Medidata Launches Bundled Solutions to Support Oncology and Vaccine Trials

Medidata, a Dassault Systèmes brand and leading provider of...

Blend Appoints Mike Mischel as SVP of AI Consulting

Blend, a leader in data science and AI-powered solutions,...

Patronus AI Launches Industry-First Self-Serve API for AI Evaluation and Guardrails

Patronus AI announced the launch of the Patronus API, the first...
spot_imgspot_img

ODAIA is first company to join Veeva AI Partner Program and provide industry’s first GenAI solution for Veeva Vault CRM

ODAIA announced it is expanding its product partnership with Veeva Systems, joining the Veeva AI Partner Program to advance the use of Generative AI (GenAI) in life sciences. As the first product partner in the program, ODAIA will deliver an integrated GenAI solution that provides real-time, predictive insights right in Veeva Vault CRM. Sales teams will be able to enhance call planning and pre-call planning to drive more targeted, relevant, timely, and personalized engagement with healthcare professionals (HCPs).

The ODAIA platform, MAPTUAL, is the first and only Customer Science cloud for pharma that combines data science and behavioral science with AI and machine learning to gain a deep understanding of HCPs and their patients’ journeys. MAPTUAL analyzes vast amounts of data to predict future HCP behavioral trends and prescribing patterns in real time. Innovative companies, including three of the top 15 largest biopharma organizations, use ODAIA to improve HCP targeting and engagement and get treatments to patients faster.

“GenAI is a new technology that is rapidly evolving. Veeva’s strategy is to enable our customers and partners to develop AI solutions that work well with any Veeva Vault application,” said Paul Shawah, executive vice president of commercial strategy at Veeva. “Giving sales reps AI-driven, real-time insights can simplify and enhance pre-call planning, which can drive more valued engagement with HCPs.”

Also Read: OM1 Launches Three New Products Powered by Patented AI Platform to Expedite Delivery of Personalized Medicine

Typical GenAI copilot approaches depend on users writing multiple prompts to generate the desired answers and outputs, but results are often inconsistent. The ODAIA GenAI solution features a guided-large language model (LLM) designed to automatically ingest and process data. Now companies can surface and deliver summarized insights for sales reps with greater accuracy the first time – all without user-generated prompts.

ODAIA tells sales reps everything they need to know before visiting an HCP, from prescribing behavior and competitive insights to patient triggers and personal and non-personal promotional activities. Using the Vault Direct Data API to access Vault CRM data, the ODAIA LLM engine will provide tailored insights instantly in Vault CRM, giving sales reps details directly within their current workflow as they prepare for their week, day, or individual call.

“Sales leaders want their teams focused on engaging HCPs, not prompt engineering and figuring out the right questions to ask a copilot tool. Our LLM engine automatically delivers insights users wouldn’t even think to ask about,” said Philip Poulidis, CEO at ODAIA. “With Veeva’s high-speed Direct Data API, we can provide sales reps with clear and actionable real-time details in Veeva Vault CRM to enhance the entire HCP engagement process, making it more timely, relevant, and effective.”

Source: PRNewsWire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img